相关产品推荐更多 >

Tocris货号3509现货BMS 493上海睿安生物R&D Systems-Tocris官方正式授权代理19121878899
¥3640.01
现货Sigma货号C8027硫酸铜五水合物13611631389上海睿安生物
¥1293.93
美天旎Miltenyi货号130-109-398碎片去除试剂盒Debris Removal Solution(DRS)碎片清除溶液13611631389上海睿安生物
¥3456.67
Sigma货号M8386现货AMP-CP α,β-亚甲基腺苷 5'-二磷酸钠盐13611631389上海睿安生物
¥9353.07
Sigma货号L4408氯化锂Lithium chloride上海睿安生物13611631389
¥2838.42
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 英文名:
IRAK1/4 Inhibitor I
- CAS号:
509093-47-4
- 保质期:
1年
- 保存条件:
−20°C
- 库存:
30⁺瓶
- 供应商:
上海睿安生物19121878899
- 规格:
50mg/瓶
Tocris货号5665-10mg现货IRAK1/4 Inhibitor I上海睿安生物19121878899
安迪Bio-Techne(R&D Systems-Tocris)官方正式授权代理商
Tocris货号5665-50mg现货IRAK1/4 Inhibitor I上海睿安生物19121878899
Chemical Name:N-[1-[2-(4-Morpholinyl)ethyl]-1H-benzimidazol-2-yl]-3-nitroben_zamide
Purity:≥98%
Biological Activity
IRAK1/4 Inhibitor I is an IRAK4 and IRAK1 inhibitor (IC50 values are 0.2 and 0.3 μM, respectively).Technical Data
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.
Background References
- Discovery and initial SAR of inhibitors of interleukin-1 receptor-associated kinase-4.
Powers et al.
Bioorg.Med.Chem.Lett., 2006;16:2842 - Bcl10 Regulates Lipopolysaccharide-Induced Pro-Fibrotic Signaling in Bronchial Fibroblasts from Severe Asthma Patients
RK Ramakrishn, K Bajbouj, M Guimei, SS Rawat, Z Kalaji, MY Hachim, B Mahboub, SM Ibrahim, R Hamoudi, R Halwani, Q Hamid
Biomedicines, 2022;10(7):.
Citation for IRAK1/4 Inhibitor I
The citations listed below are publications that use Tocris products. Selected citations for IRAK1/4 Inhibitor I include:
1 Citation: Showing 1 - 1
- SIGIRR Mutation in Human Necrotizing Enterocolitis (NEC) Disrupts STAT3-Dependent microRNA Expression in Neonatal Gut.
Authors: Shahid Et al.
Cell Mol Gastroenterol Hepatol 2021;13:425-440




风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Tocris货号5665-10mg现货IRAK1/4 Inhibitor I上海睿安生物19121878899
安迪Bio-Techne(R&D Systems-Tocris)官方正式授权代理商
Tocris货号5665-50mg现货IRAK1/4 Inhibitor I上海睿安生物19121878899
Chemical Name:N-[1-[2-(4-Morpholinyl)ethyl]-1H-benzimidazol-2-yl]-3-nitroben_zamide
Purity:≥98%
Biological Activity
IRAK1/4 Inhibitor I is an IRAK4 and IRAK1 inhibitor (IC50 values are 0.2 and 0.3 μM, respectively).Technical Data
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.
Background References
- Discovery and initial SAR of inhibitors of interleukin-1 receptor-associated kinase-4.
Powers et al.
Bioorg.Med.Chem.Lett., 2006;16:2842 - Bcl10 Regulates Lipopolysaccharide-Induced Pro-Fibrotic Signaling in Bronchial Fibroblasts from Severe Asthma Patients
RK Ramakrishn, K Bajbouj, M Guimei, SS Rawat, Z Kalaji, MY Hachim, B Mahboub, SM Ibrahim, R Hamoudi, R Halwani, Q Hamid
Biomedicines, 2022;10(7):.
Citation for IRAK1/4 Inhibitor I
The citations listed below are publications that use Tocris products. Selected citations for IRAK1/4 Inhibitor I include:
1 Citation: Showing 1 - 1
- SIGIRR Mutation in Human Necrotizing Enterocolitis (NEC) Disrupts STAT3-Dependent microRNA Expression in Neonatal Gut.
Authors: Shahid Et al.
Cell Mol Gastroenterol Hepatol 2021;13:425-440




Figure 1. DUB assays with Ub‐VS‐untreated 26 proteasome (A , 26S) or Ub‐VS‐treated 26 proteasome (B , VS‐26S) in the USP14 reconstitution system. Ub‐VS is a commercially available active‐site‐directed inhibitor that irreversibly inactivates thiol
Studies of the Ubiquitin Proteasome System
or other proteasome inhibitor (e.g., lactacystin; Calbiochem or Biomol) Phosphate‐buffered saline (PBS; see recipe ) Nondenaturing Triton X‐100 lysis buffer (see recipe ) containing 1×
Nucleic Acid Programmable Protein Arrays: Versatile Tools for Array‐Based Functional Protein Studies
‐88. Ernst, V., Levin, D.H., Foulkes, J.G., and London, I.M. 1982. Effects of skeletal muscle protein phosphatase inhibitor‐2 on protein synthesis and protein






